While finished drug products are intended for eventual human consumption, many of the raw materials and chemicals used to make these products require special safety considerations. Here are some tools to help CDMOs safely manage these important materials:
Transformation Check List – Growing into a CDMO
Even with an existing cGMP compliant organization and quality structure in place, bringing on a new service is a big job. Here are some checks to think about when expanding into a new service, specifically aseptic manufacturing:
Behind Singota Solutions
Change is risky, but there were important reasons to undertake a rebranding effort. Here’s insight on why we transitioned to Singota Solutions.
Coffee and Quiche with Indiana’s Life Sciences Industry Leaders at IBJ’s Life Sciences Power Breakfast
Questions to the panelists Friday morning at Indianapolis Business Journal’s Life Sciences Power Breakfast all revolved around a central theme: how to overcome challenges faced by the life sciences community in Indiana. The panelists, P. Ron Ellis from Endocyte, David L. Johnson from BioCrossroads, Wade Lange from Lange Advisors, Ping Poulsen fom Safis Solutions, William Weldon from Elanco, and Alisa Wright from BioConvergence, all provided their insights to a room filled with 300 interested life science community members. Notable takeaways from this event include:
- Page 2 of 2
- 1
- 2